Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury [8]

Clinical Chemistry

Volumn 51, Issue 7, 2005, Pages 1305-1307

  Feng, Xiao ^a   Taggart, Peter ^a   Hall, LeRoy ^a   Bryant, Stewart ^a   Sansone, Joseph ^a   Kemmerer, Michael ^a   Herlich, Judy ^a   Lord, Peter ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; ISOPRENALINE; TROPONIN I; TROPONIN T; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INJURY; IMMUNOASSAY; LABORATORY TEST; LETTER; MALE; NONHUMAN; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; HEART DISEASE; HEART MUSCLE; METABOLISM;

ANIMALIA; CANIS FAMILIARIS;

ADRENERGIC BETA-AGONISTS; ANIMALS; BIOLOGICAL MARKERS; CREATINE KINASE; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HEART DISEASES; ISOPROTERENOL; MALE; MYOCARDIUM; SYMPATHOMIMETICS; TROPONIN I; TROPONIN T;

EID: 23444439499     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.049643     Document Type: Letter

References (8)

1. Wu AH. Analytical issues affecting the clinical performance of cardiac troponin assays. In: Adams JE 3rd, Apple FS, Jaffe AS, Wu AH, eds. Markers in cardiology: current and future clinical applications. Armonk, NY: Futura Publishing Company, 2001.
2. Wallace KB, Hausner E, Herman E, Holt GD, MacGregor JT, Metz AL, et al. Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol Pathol 2004;32:106-21.
3. Balazs T, Bloom S. Cardiotoxicity of adrenergic bronchodilator and vasodilating antihypertensive drugs. In: Van Stee EW, ed. Cardiovascular toxicology. New York: Raven Press, 1982:199-220.
4. Szasz G, Gruber W, Bernt E. Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 1976;22:650-6.
5. Sullebarger JT, Fan TH, Torres F, Liang CS. Both cell surface and internalized β-adrenoceptors are reduced in the failing myocardium. Eur J Pharmacol 1991;205:165-9.
6. Apple FS, Murakami M, Panteghini M, Christenson RH, Dati F, Mair J, et al. International survey on the use of cardiac markers. Clin Chem 2001;47:587-8.
7. Bertinchant JP, Robert E, Folge A, Marty-Double C, Fabbro-Peray P, Poirey S, et al. Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta 2000;298:13-28.
8. Bleuel H, Deschl U, Bertsch T, Bolz G, Rebel W. Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage. Exp Toxicol Pathol 1995;47:121-7.